![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 2212-3989|6|1|43-56
ISSN: 1871-5265
Source: Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol.6, Iss.1, 2006-03, pp. : 43-56
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Locked Nucleic Acid Holds Promise in the Treatment of Cancer
Current Pharmaceutical Design, Vol. 14, Iss. 11, 2008-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Chemical modifications of nucleic acids for RNA-based therapeutics
By Grünweller Arnold Hartmann Roland K.
PHARMAKON, Vol. 3, Iss. 4, 2015-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Nanostructured Hyaluronic Acid-based Materials for the Delivery of siRNA
Current Pharmaceutical Design, Vol. 24, Iss. 23, 2018-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cellular Delivery In Vivo of siRNA-Based Therapeutics
Current Pharmaceutical Design, Vol. 14, Iss. 34, 2008-12 ,pp. :